Histogen Inc. (HSTOQ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 17, 2025, 4:00 PM EDT
Histogen Revenue
Histogen had revenue of $5 thousand in the quarter ending September 30, 2023. This brings the company's revenue in the last twelve months to $19 thousand, down -99.50% year-over-year. In the year 2022, Histogen had annual revenue of $3.77 million with 265.21% growth.
Revenue (ttm)
19.00K
Revenue Growth
-99.50%
P/S Ratio
0.04
Revenue / Employee
2.71K
Employees
7
Market Cap
854.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 3.77M | 2.74M | 265.21% |
| Dec 31, 2021 | 1.03M | -1.03M | -49.88% |
| Dec 31, 2020 | 2.06M | -9.40M | -82.02% |
| Dec 31, 2019 | 11.45M | 9.68M | 544.57% |
| Dec 31, 2018 | 1.78M | -7.87M | -81.58% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |